Found: 51
Select item for more details and to access through your institution.
Timing of chemotherapy-induced neutropenia predicts prognosis in metastatic colon cancer patients: a retrospective study in mFOLFOX6 -treated patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Nab-paclitaxel plus S-1 with or without PD-1 inhibitor in pancreatic ductal adenocarcinoma with only hepatic metastases: a retrospective cohort study.
- Published in:
- Langenbeck's Archives of Surgery, 2022, v. 407, n. 2, p. 633, doi. 10.1007/s00423-021-02321-7
- By:
- Publication type:
- Article
A composite indicator of derived neutrophil-lymphocyte ratio and lactate dehydrogenase correlates with outcomes in pancreatic carcinoma patients treated with PD-1 inhibitors.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.951985
- By:
- Publication type:
- Article
Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.926260
- By:
- Publication type:
- Article
Fruquintinib in Combination With PD-1 Inhibitors in Patients With Refractory Non-MSI-H/pMMR Metastatic Colorectal Cancer: A Real-World Study in China.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.851756
- By:
- Publication type:
- Article
S-1 Maintenance Therapy After First-Line Treatment With Nab-Paclitaxel Plus S-1 for Advanced Pancreatic Adenocarcinoma: A Real-World Study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.865404
- By:
- Publication type:
- Article
Immune function of colon cancer associated miRNA and target genes.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1203070
- By:
- Publication type:
- Article
PD-1 inhibitors-based second-line therapy for metastatic gastric cancer.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1136437
- By:
- Publication type:
- Article
The Prognostic Value of the Prognostic Nutritional Index in Patients with Advanced or Metastatic Gastric Cancer Treated with Immunotherapy.
- Published in:
- Nutrients, 2023, v. 15, n. 19, p. 4290, doi. 10.3390/nu15194290
- By:
- Publication type:
- Article
Association between Dietary Vitamin E Intake and Human Papillomavirus Infection among US Adults: A Cross-Sectional Study from National Health and Nutrition Examination Survey.
- Published in:
- Nutrients, 2023, v. 15, n. 17, p. 3825, doi. 10.3390/nu15173825
- By:
- Publication type:
- Article
The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma.
- Published in:
- Signal Transduction & Targeted Therapy, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41392-020-00256-x
- By:
- Publication type:
- Article
Identification of Small Nucleolar RNA SNORD60 as a Potential Biomarker and Its Clinical Significance in Lung Adenocarcinoma.
- Published in:
- BioMed Research International, 2022, p. 1, doi. 10.1155/2022/5501171
- By:
- Publication type:
- Article
Correction: Prognosis of patients with advanced bile tract carcinoma: assessment using the modified-Gustave Roussy Immune score (mGRIm-s) as a clinico-immunological tool.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Prognosis of patients with advanced bile tract carcinoma: assessment using the modified-Gustave Roussy Immune Score (mGRIm-s) as a clinico-immunological tool.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 5, p. 1, doi. 10.1007/s00432-024-05771-w
- By:
- Publication type:
- Article
The Role of Serum CEA and CA19-9 in Efficacy Evaluations and Progression-Free Survival Predictions for Patients Treated with Cetuximab Combined with FOLFOX4 or FOLFIRI as a First-Line Treatment for Advanced Colorectal Cancer.
- Published in:
- Disease Markers, 2019, p. 1, doi. 10.1155/2019/6812045
- By:
- Publication type:
- Article
Case Report and Literature Review: Diagnosis, Tailored Genetic Counseling and Cancer Prevention for a Locally Advanced dMMR/MSI-H/TMB-H Lung Cancer Patient With Concurrent Lynch Syndrome Mediated by a Rare PMS2 Splicing Variant (c.1144+1G>A).
- Published in:
- Frontiers in Genetics, 2022, v. 12, p. 1, doi. 10.3389/fgene.2021.799807
- By:
- Publication type:
- Article
Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2).
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28408-3
- By:
- Publication type:
- Article
Correlation Between Baseline Serum Tumor Markers and Clinical Characteristic Factors in Patients with Advanced Pancreatic Cancer.
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 11151, doi. 10.2147/OTT.S269720
- By:
- Publication type:
- Article
Programmed Cell Death Protein-1 (PD-1)-Targeted Immunotherapy for Advanced Hepatocellular Carcinoma in Real World.
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 143, doi. 10.2147/OTT.S234868
- By:
- Publication type:
- Article
Efficacy and safety of nivolumab for metastatic biliary tract cancer.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 861, doi. 10.2147/OTT.S195537
- By:
- Publication type:
- Article
Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
- Published in:
- Clinical Epigenetics, 2018, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13148-018-0501-4
- By:
- Publication type:
- Article
Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Neutrophil-to-Lymphocyte Ratio (NLR) Predicts PD-1 Inhibitor Survival in Patients with Metastatic Gastric Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
microRNA-425 promoted the proliferation and migration of colorectal cancer cells by targeting KLF3 through the PI3K/AKT pathway.
- Published in:
- Minerva Medica, 2021, v. 112, n. 4, p. 537, doi. 10.23736/S0026-4806.19.06378-X
- By:
- Publication type:
- Article
Expression and prognostic significance of doublecortin‑like kinase 1 in patients with hepatocellular carcinoma.
- Published in:
- Oncology Letters, 2017, v. 14, n. 6, p. 7529, doi. 10.3892/ol.2017.7082
- By:
- Publication type:
- Article
Construction of a nomogram to predict the survival of metastatic gastric cancer patients that received immunotherapy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.950868
- By:
- Publication type:
- Article
Evaluation of docetaxel- and oxaliplatin-based adjuvant chemotherapy in postgastrectomy gastric cancer patients reveals obvious survival benefits in docetaxel-treated mixed signet ring cell carcinoma patients.
- Published in:
- Medical Oncology, 2014, v. 31, n. 9, p. 1, doi. 10.1007/s12032-014-0159-5
- By:
- Publication type:
- Article
A Chinese Retrospective Multicenter Study of First-Line Chemotherapy for Advanced Pancreatic Cancer.
- Published in:
- Medical Science Monitor, 2020, v. 26, p. 1, doi. 10.12659/MSM.927654
- By:
- Publication type:
- Article
Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancer.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-11823-8
- By:
- Publication type:
- Article
Comparison of efficacy and safety between PD-1 inhibitors and PD-L1 inhibitors plus platinum-etoposide as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, real-world analysis.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11709-1
- By:
- Publication type:
- Article
HIF-1 Alpha Overexpression Correlates with Poor Overall Survival and Disease-Free Survival in Gastric Cancer Patients Post-Gastrectomy.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0090678
- By:
- Publication type:
- Article
CD19<sup>lo</sup>CD27<sup>hi</sup> Plasmablasts Suppress Harmful Th17 Inflammation Through Interleukin 10 Pathway in Colorectal Cancer.
- Published in:
- DNA & Cell Biology, 2017, v. 36, n. 10, p. 870, doi. 10.1089/dna.2017.3814
- By:
- Publication type:
- Article
Dysregulation of Circulating Follicular Helper T Cells in Nonsmall Cell Lung Cancer.
- Published in:
- DNA & Cell Biology, 2014, v. 33, n. 6, p. 355, doi. 10.1089/dna.2013.2332
- By:
- Publication type:
- Article
Relationship between four tumor-associated bio-markers and prognosis of gastric cancer.
- Published in:
- Tropical Journal of Pharmaceutical Research, 2017, v. 16, n. 6, p. 1245, doi. 10.4314/tjpr.v16i6.6
- By:
- Publication type:
- Article
PD-1 inhibitor combined with albumin paclitaxel and apatinib as second-line treatment for patients with metastatic gastric cancer: a single-center, single-arm, phase II study.
- Published in:
- Investigational New Drugs, 2024, v. 42, n. 2, p. 171, doi. 10.1007/s10637-024-01425-3
- By:
- Publication type:
- Article
Gene signature developed for predicting early relapse and survival in early-stage pancreatic cancer.
- Published in:
- BJS Open, 2023, v. 7, n. 3, p. 1, doi. 10.1093/bjsopen/zrad031
- By:
- Publication type:
- Article
Hyperprogressive Disease Caused by PD-1 Inhibitors for the Treatment of Pan-Cancer.
- Published in:
- Disease Markers, 2021, p. 1, doi. 10.1155/2021/6639366
- By:
- Publication type:
- Article
Effect and safety of bevacizumab-containing chemotherapy treatment in Chinese patients with metastatic colorectal cancer.
- Published in:
- OncoTargets & Therapy, 2013, v. 6, p. 485, doi. 10.2147/OTT.S41449
- By:
- Publication type:
- Article
Timing of chemotherapy‐induced neutropenia is a prognostic factor in patients with advanced gastric cancer undergoing first‐line chemotherapy with oxaliplatin and capecitabine: a retrospective study.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 4, p. 997, doi. 10.1002/cam4.1308
- By:
- Publication type:
- Article
Retinoic Acid-Induced 2 (RAI2) Is a Novel Antagonist of Wnt/β-Catenin Signaling Pathway and Potential Biomarker of Chemosensitivity in Colorectal Cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.805290
- By:
- Publication type:
- Article
A Composite Biomarker of Derived Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio Correlates With Outcomes in Advanced Gastric Cancer Patients Treated With Anti-PD-1 Antibodies.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2021.798415
- By:
- Publication type:
- Article
PD-1 Inhibitors Could Improve the Efficacy of Chemotherapy as First-Line Treatment in Biliary Tract Cancers: A Propensity Score Matching Based Analysis.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.648068
- By:
- Publication type:
- Article
The Prognostic Value of Pre-treatment Hemoglobin (Hb) in Patients With Advanced or Metastatic Gastric Cancer Treated With Immunotherapy.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.655716
- By:
- Publication type:
- Article
Conclusiveness of the Cochrane Reviews in Palliative and Supportive Care for Cancer: A Systematic Analysis.
- Published in:
- American Journal of Hospice & Palliative Medicine, 2017, v. 34, n. 1, p. 53, doi. 10.1177/1049909115605058
- By:
- Publication type:
- Article
High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to first-line nab-paclitaxel plus S-1: prospective study.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-04989-z
- By:
- Publication type:
- Article
Effect of colourants on the optical characteristics and structure of Y<sub>2</sub>O<sub>3</sub> stabilised tetragonal zirconia ceramic.
- Published in:
- Coloration Technology, 2021, v. 137, n. 5, p. 493, doi. 10.1111/cote.12546
- By:
- Publication type:
- Article
Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer.
- Published in:
- Gastric Cancer, 2016, v. 19, n. 1, p. 234, doi. 10.1007/s10120-015-0457-4
- By:
- Publication type:
- Article
Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study).
- Published in:
- Gastric Cancer, 2015, v. 18, n. 1, p. 168, doi. 10.1007/s10120-014-0351-5
- By:
- Publication type:
- Article
The suppressive efficacy of THZ1 depends on KRAS mutation subtype and is associated with super‐enhancer activity and the PI3K/AKT/mTOR signalling in pancreatic ductal adenocarcinoma: A hypothesis‐generating study.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 12, p. 1, doi. 10.1002/ctm2.1500
- By:
- Publication type:
- Article
Histone demethylase PHF8 accelerates the progression of colorectal cancer and can be regulated by miR‑488 in vitro.
- Published in:
- Molecular Medicine Reports, 2017, v. 16, n. 4, p. 4437, doi. 10.3892/mmr.2017.7130
- By:
- Publication type:
- Article